Tue 5/26/2020 20:32 ET
DJIA24995.11542.392.17%TELCO166.222.661.60%GOLD1704.800.850.05%Shanghai2846.5528.751.01%
S&P 5002991.7736.801.23%BANKS335.3526.327.85%OIL33.920.431.27%BITCOIN8847.0913.270.15%
NASDAQ9340.2215.880.17%PHARM599.690.420.07%US/EU1.100.000.00%Futures2986.627.770.26%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - DepoMed - DEPO   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add DEPO
  
From: bdawgp (Rep: 343)Date: 10/06/2015 20:45
Forum: DepoMed - Msg #293Thread #673784810 (Rec: 0)
still trading around 18, anything under 20 is another gift from this bio selloff...less than 8 forward p/e and only 2x rev's estimates for 2017 per Zacks

"Based on our long term financial model, revenue will reach $352 million in 2015 with non-GAAP earnings per share (EPS) of $1.00. We continue to expect that the NUCYNTA® / ER deal will be strongly accretive, and that Depomed will generate $400 million in sales from NUCYNTA franchise in 2017. Non-GAAP EPS will grow from $1.00 in 2015 to $2.30 in 2017 based on total revenue of $624 million. "



disclaimer: good luck, markets are systems to fool the masses

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser bdawgp: Reward | Watch | IgnoreDEPO: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add DEPO
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.